NO20021476L - Farmasöytisk b¶rerformulering - Google Patents
Farmasöytisk b¶rerformuleringInfo
- Publication number
- NO20021476L NO20021476L NO20021476A NO20021476A NO20021476L NO 20021476 L NO20021476 L NO 20021476L NO 20021476 A NO20021476 A NO 20021476A NO 20021476 A NO20021476 A NO 20021476A NO 20021476 L NO20021476 L NO 20021476L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical
- borer
- formulation
- fatty acid
- acid esters
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- 229930006000 Sucrose Natural products 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 2
- 239000005720 sucrose Substances 0.000 abstract 2
- -1 sucrose fatty acid esters Chemical class 0.000 abstract 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 abstract 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 abstract 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 abstract 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 abstract 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 abstract 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 abstract 1
- 235000019445 benzyl alcohol Nutrition 0.000 abstract 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 abstract 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40616499A | 1999-09-27 | 1999-09-27 | |
| PCT/US2000/026381 WO2001022942A1 (en) | 1999-09-27 | 2000-09-26 | Pharmaceutical carrier formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20021476D0 NO20021476D0 (no) | 2002-03-25 |
| NO20021476L true NO20021476L (no) | 2002-04-16 |
Family
ID=23606801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20021476A NO20021476L (no) | 1999-09-27 | 2002-03-25 | Farmasöytisk b¶rerformulering |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1216029A1 (cs) |
| JP (1) | JP2003510267A (cs) |
| KR (1) | KR20020064289A (cs) |
| CN (1) | CN1399542A (cs) |
| AR (1) | AR025867A1 (cs) |
| AU (1) | AU7716100A (cs) |
| BR (1) | BR0014308A (cs) |
| CA (1) | CA2388471A1 (cs) |
| CZ (1) | CZ20021082A3 (cs) |
| EA (1) | EA200200415A1 (cs) |
| HK (1) | HK1044485A1 (cs) |
| HU (1) | HUP0202652A3 (cs) |
| IL (1) | IL148543A0 (cs) |
| MX (1) | MXPA02003190A (cs) |
| NO (1) | NO20021476L (cs) |
| PL (1) | PL354331A1 (cs) |
| WO (1) | WO2001022942A1 (cs) |
| ZA (1) | ZA200203311B (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7138393B2 (en) | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
| US20030105144A1 (en) * | 2001-04-17 | 2003-06-05 | Ping Gao | Stabilized oral pharmaceutical composition |
| WO2004073692A1 (ja) * | 2003-02-18 | 2004-09-02 | Yamashita, Shinji | 難水溶性薬物のハードカプセル剤 |
| CN100342856C (zh) * | 2003-04-10 | 2007-10-17 | 上海医药工业研究院 | 达那唑半固体骨架制剂的组合物 |
| CN101351196B (zh) | 2005-10-26 | 2013-07-03 | 班纳制药公司 | 作为胶囊填充物的基于亲脂性载体的双重控释基质系统 |
| JP5406530B2 (ja) * | 2005-10-26 | 2014-02-05 | バナー ファーマキャプス， インコーポレイテッド | 親水性ベヒクルに基づく二重制御された放出マトリクスシステム |
| WO2008055148A2 (en) * | 2006-10-31 | 2008-05-08 | Wyeth | Semi-solid formulations of phospholipase enzyme inhibitors |
| BR112020003233B1 (pt) | 2017-12-20 | 2023-11-07 | Firmenich S.A. | Composições para cuidado oral |
| EP3733826B1 (en) * | 2019-05-03 | 2024-07-17 | The Procter & Gamble Company | Particle treatment compositions comprising an antioxidant |
| AU2023292098A1 (en) * | 2022-06-13 | 2025-01-16 | R.P. Scherer Technologies, Llc | Enteric bisacodyl softgel capsule |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3636123A1 (de) * | 1986-10-23 | 1988-05-05 | Rentschler Arzneimittel | Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten |
| WO1995022331A1 (en) * | 1994-02-18 | 1995-08-24 | Cephalon, Inc. | Aqueous indolocarbazole solutions |
| US6287594B1 (en) * | 1998-01-20 | 2001-09-11 | Edward S. Wilson | Oral liquid compositions |
-
2000
- 2000-09-26 JP JP2001526154A patent/JP2003510267A/ja active Pending
- 2000-09-26 WO PCT/US2000/026381 patent/WO2001022942A1/en not_active Ceased
- 2000-09-26 IL IL14854300A patent/IL148543A0/xx unknown
- 2000-09-26 CN CN00816307A patent/CN1399542A/zh active Pending
- 2000-09-26 AR ARP000105037A patent/AR025867A1/es unknown
- 2000-09-26 EA EA200200415A patent/EA200200415A1/ru unknown
- 2000-09-26 CA CA002388471A patent/CA2388471A1/en not_active Abandoned
- 2000-09-26 AU AU77161/00A patent/AU7716100A/en not_active Abandoned
- 2000-09-26 MX MXPA02003190A patent/MXPA02003190A/es unknown
- 2000-09-26 CZ CZ20021082A patent/CZ20021082A3/cs unknown
- 2000-09-26 HK HK02106196.7A patent/HK1044485A1/zh unknown
- 2000-09-26 HU HU0202652A patent/HUP0202652A3/hu unknown
- 2000-09-26 PL PL00354331A patent/PL354331A1/xx not_active Application Discontinuation
- 2000-09-26 EP EP00966880A patent/EP1216029A1/en not_active Withdrawn
- 2000-09-26 KR KR1020027003934A patent/KR20020064289A/ko not_active Withdrawn
- 2000-09-26 BR BR0014308-1A patent/BR0014308A/pt not_active Application Discontinuation
-
2002
- 2002-03-25 NO NO20021476A patent/NO20021476L/no not_active Application Discontinuation
- 2002-04-25 ZA ZA200203311A patent/ZA200203311B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL354331A1 (en) | 2004-01-12 |
| EA200200415A1 (ru) | 2002-10-31 |
| BR0014308A (pt) | 2002-05-21 |
| WO2001022942A1 (en) | 2001-04-05 |
| AU7716100A (en) | 2001-04-30 |
| HUP0202652A2 (hu) | 2004-05-28 |
| IL148543A0 (en) | 2002-09-12 |
| HK1044485A1 (zh) | 2002-10-25 |
| CA2388471A1 (en) | 2001-04-05 |
| AR025867A1 (es) | 2002-12-18 |
| ZA200203311B (en) | 2003-12-31 |
| MXPA02003190A (es) | 2002-09-30 |
| JP2003510267A (ja) | 2003-03-18 |
| EP1216029A1 (en) | 2002-06-26 |
| KR20020064289A (ko) | 2002-08-07 |
| HUP0202652A3 (en) | 2004-06-28 |
| CN1399542A (zh) | 2003-02-26 |
| CZ20021082A3 (cs) | 2002-06-12 |
| NO20021476D0 (no) | 2002-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2328950A1 (en) | Piperidinopyrimidine derivatives for topical application | |
| CY1114631T1 (el) | Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο | |
| WO1998040069A3 (en) | Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations | |
| IE871335L (en) | Steroid formulations. | |
| ITFI930247A1 (it) | Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche. | |
| ES2110377T1 (es) | Formulacion galenica de fenofibrato y aplicacion de la misma. | |
| EP0215423A3 (en) | Transdermally resorbable aqueous compositions of arylpropionic-acid derivatives and process for their preparation | |
| WO1998020872B1 (en) | Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections | |
| CA2058428A1 (en) | Analgesic formulations | |
| CA2337745A1 (en) | Human growth hormone aqueous formulation | |
| IL102633A0 (en) | Compositions | |
| PT918507E (pt) | Formulacoes em aerossol | |
| CA2519351A1 (en) | Controlled release system | |
| WO1999051271A3 (en) | Compositions comprising glycol derivatives and alcohols | |
| MX9204382A (es) | Composiciones | |
| EP1886691A3 (en) | A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug | |
| HK1044485A1 (zh) | 药物载体配方 | |
| PE20030545A1 (es) | Formulaciones de jarabe de ribavirina | |
| CA2264693A1 (en) | Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation | |
| WO2021216450A8 (en) | Opioid antagonist formulations | |
| WO2001022969A3 (en) | Vasopressin agonist formulation and process | |
| DE60017938D1 (de) | Arzneizusammensetzungen und herstellungsverfahren von ergotalkaloidhaltigen arzneizusammensetzungen mit verzögerter wirkstoffabgabe und verbesserter bioverfügbarkeit | |
| JP2003526680A5 (cs) | ||
| EP0056681A3 (en) | Levonantradol and n-methyllevonantradol formulations | |
| WO2001003774A3 (en) | Pharmaceutical composition for the treatment of calcification |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |